Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

Por Auel, Britta, Goldschmidt, Hartmut, Geer, Thomas, Moehler, Thomas M., Platzbecker, Uwe, Naumann, Ralph, Blau, Igor, Hänel, Mathias, Knauf, Wolfgang, Nückel, Holger, Salwender, Hans-Jürgen, Scheid, Christof, Weisel, Katja, Gorschlüter, Marcus, Glasmacher, Axel, Schmidt-Wolf, Ingo G. H.
Publicado em 2011